Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine within the scope of the trial what the maximum
tolerated dose (MTD) of lenalidomide in combination with AVD should be.